An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder

NCT00746967 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Sexual Dysfunctions, Psychological
Sexual Arousal Disorder

Interventions

DRUG: sildenafil

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.